GLOBAL (NORTH AMERICA, EUROPE, ASIA-PACIFIC, SOUTH AMERICA, MIDDLE EAST AND AFRICA) HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 2018, FORECAST TO 2023

Jan 2019 129

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Viscosupplementation is the treatment for Osteoarthritis which is the most common joint disease affecting the middle age to an elderly section of the people. In this method, doses of hyaluronic acid are given through injections in affected joints in the synovial fluid. The course of treatment can be of a single-injection formulation or subsequent doses of multiple-injection (three-injection) formulation. Viscosupplementation helps in reducing pain and improving joint movements.

Scope of the Report:
This report focuses on the Hyaluronic Acid Viscosupplementation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Hyaluronic Acid Viscosupplementation is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
- Anika Therapeutics
- Synvisc - One
- Supartz
- Zimme
- Swiss biomed Orthopaedics
- Carbylan Therapeutics
- Croma-Pharma
- Laboratoire Genevrier
- Meda Pharma
- TRB Chemedica
- Tedec Meiji

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Single Injection
- Multiple Injection

Market Segment by Applications, can be divided into
- Hospitals
- Ambulatory Surgical Centers

There are 15 Chapters to deeply display the global Hyaluronic Acid Viscosupplementation market.
Chapter 1, to describe Hyaluronic Acid Viscosupplementation Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hyaluronic Acid Viscosupplementation, with sales, revenue, and price of Hyaluronic Acid Viscosupplementation, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hyaluronic Acid Viscosupplementation, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hyaluronic Acid Viscosupplementation market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hyaluronic Acid Viscosupplementation sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(Jan 19)

Apigenin is a polyphenol, and is one of the flavonoids found in many of the foods consumed by humans. Scope of the Report:...

(Jan 19)

Aplastic anaemia is a rare disease in which the bone marrow and the hematopoietic stem cells that reside there are damaged. S...

(Jan 19)

Aplastic anaemia is a rare disease in which the bone marrow and the hematopoietic stem cells that reside there are damaged. S...

(Jan 19)

Aplastic anaemia is a rare disease in which the bone marrow and the hematopoietic stem cells that reside there are damaged. S...

(Jan 19)

Eltrombopag (rINN, codenamed SB-497115-GR) is a medication that has been developed for certain conditions that lead to thrombocytopenia (abn...

(Jan 19)

Eltrombopag (rINN, codenamed SB-497115-GR) is a medication that has been developed for certain conditions that lead to thrombocytopenia (abn...

GLOBAL (NORTH AMERICA, EUROPE, ASIA-PACIFIC, SOUTH AMERICA, MIDDLE EAST AND AFRICA) HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 2018, FORECAST TO 2023


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy